Get personalized genetic insights and tools that can help make it easier for you to take action on your health.
- 150+ personalized reports
- Includes Ancestry Service
There is a lot to consider with genetic testing. We encourage you to review relevant information about Carrier Status*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks and Genetic Health Risk*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks reports.
Important test infoDiscover how your DNA can influence your health.
Using insights backed by the latest science, see how your DNA can affect your chances of developing certain health conditions. Your personalized reports break down your genetic data, the science and potential next steps.
(Powered by 23andMe
Research)Reports and features that are “Powered by 23andMe Research” are developed by 23andMe scientists using data and insights gathered from thousands of customers who have consented to participate in our research.(Selected Variants)
Type 2 Diabetes (Powered by 23andMe
Research)Reports and features that are “Powered by 23andMe Research” are developed by 23andMe scientists using data and insights gathered from thousands of customers who have consented to participate in our research.
Explore how your DNA relates to your lifestyle.
Discover what your DNA has to say about lifestyle factors like diet, exercise, and sleep. Use what you've learned to help you make informed decisions.
Muscle Composition
See what you may pass on to your future children.
If you’re thinking of starting a family, find out if you’re a carrier for genetic variants linked to certain inherited health conditions.
Cystic Fibrosis
Check out the reports and insights included in our Health plus Ancestry Service.
- Ancestry Detail Reports (48 reports)
Population-specific reports with maps covering 3500+ regions, offering a granular view of your ancestry, plus immersive educational content.
Reports included:
Americas (Caribbean, Mexico & Central America, Indigenous American, South America);
East Asia (Chinese, Chinese Dai, Filipino & Austronesian, Indonesian, Thai, Khmer & Myanma, Japanese, Korean, Manchurian & Mongolian, Siberian, Vietnamese);
Europe (Ashkenazi Jewish, British & Irish, Eastern European, Finnish, French & German, Greek & Balkan, Italian, Sardinian, Scandinavian, Spanish & Portuguese);
Oceania (Melanesian);
Central & South Asia (Bengali & Northeast Indian, Central Asian, Gujarati Patidar, Malayali Subgroup, Northern Indian & Pakistani, Southern Indian & Sri Lankan, Southern Indian Subgroup);
Sub-Saharan Africa (African Hunter-Gatherer, Angolan & Congolese, Ethiopian & Eritrean, Ghanaian, Liberian & Sierra Leonean, Nigerian, Senegambian & Guinean, Somali, Southern East African, Sudanese);
Western Asia & North Africa (Anatolian, Coptic Egyptian, Cypriot, Egyptian, Iranian, Caucasian & Mesopotamian, Levantine, North African, Peninsular Arab) - Family Tree
- Maternal Haplogroup
- Paternal Haplogroup
- Neanderthal Ancestry
- Ability to Match Musical Pitch
- Asparagus Odour Detection
- Back Hair (available for men only)
- Bald Spot (available for men only)
- Bitter Taste
- Bunions
- Cheek Dimples
- Cilantro Taste Aversion
- Cleft Chin
- Dandruff
- Earlobe Type
- Early Hair Loss (available for men only)
- Earwax Type
- Eye Colour
- Fear of Heights
- Fear of Public Speaking
- Finger Length Ratio
- Flat Feet
- Freckles
- Hair Photobleaching (hair lightening from the sun)
- Hair Texture
- Hair Thickness
- Ice Cream Flavour Preference
- Light or Dark Hair
- Misophonia (hatred of the sound of chewing)
- Mosquito Bite Frequency
- Motion Sickness
- Newborn Hair
- Photic Sneeze Reflex
- Red Hair
- Skin Pigmentation
- Stretch Marks
- Sweet vs. Salty
- Toe Length Ratio
- Unibrow
- Wake-Up Time
- Widow's Peak
- Type 2 Diabetes (Powered by 23andMe Research)Reports and features that are “Powered by 23andMe Research” are developed by 23andMe scientists using data and insights gathered from thousands of customers who have consented to participate in our research.Genetic likelihood for a disorder of blood sugar regulation1,000+ variants in many genes; variants found in many ethnicities
- Age-Related Macular DegenerationGenetic risk for a form of adult-onset vision loss2 variants in the ARMS2 and CFH genes; relevant for European descent
- Alpha-1 Antitrypsin DeficiencyGenetic risk for lung and liver disease2 variants in the SERPINA1 gene; relevant for European descent
- BRCA1/BRCA2 (Selected Variants)Genetic risk based on a limited set of variants for breast, ovarian, prostate and pancreatic cancer44 variants in the BRCA1 and BRCA2 genes; most relevant for Ashkenazi Jewish descent; does not include the majority of BRCA1/2 variants found in people of other ethnicities
- Celiac DiseaseGenetic risk for gluten-related autoimmune disorder2 variants near the HLA-DQB1 and HLA-DQA1 genes; relevant for European decent
- Chronic Kidney Disease (APOL1-Related)Genetic risk for a form of chronic kidney disease2 variants in the APOL1 gene; relevant for African descent
- Familial HypercholesterolemiaGenetic risk for very high cholesterol, which can increase the risk for heart disease24 variants in the LDLR and APOB genes; relevant for European, Lebanese, Old Order Amish descent
- G6PD DeficiencyGenetic risk for a form of anemia2 variants in the G6PD gene; relevant for African, Southern European, Kurdish Jewish, Middle Eastern, Central Asian, South Asian descent
- Hereditary Amyloidosis (TTR-Related)Genetic risk for a form of nerve and heart damage3 variants in the TTR gene; relevant for African American, West African, Portuguese, Brazilian, Northern Swedish, Japanese, Irish, British descent
- Hereditary Hemochromatosis (HFE‑Related)Genetic risk for iron overload2 variants in the HFE gene; relevant for European descent
- Hereditary ThrombophiliaGenetic risk for harmful blood clots2 variants in the F2 and F5 genes; relevant for European descent
- Late-Onset Alzheimer's DiseaseGenetic risk for a form of dementia1 variant in the APOE gene; variant found and studied in many ethnicities
- MUTYH-Associated PolyposisGenetic risk for a specific colorectal cancer syndrome2 variants in the MUTYH gene; relevant for Northern European descent
- Parkinson's DiseaseGenetic risk for a form of movement impairment2 variants in the LRRK2 and GBA genes; relevant for European, Ashkenazi Jewish, North African Berber descent
- ARSACS1 variant in the SACS gene; relevant for French Canadian descent
- Agenesis of the Corpus Callosum with Peripheral Neuropathy1 variant in the SLC12A6 gene; relevant for French Canadian descent
- Autosomal Recessive Polycystic Kidney Disease3 variants in the PKHD1 gene
- Beta Thalassemia and Related Hemoglobinopathies10 variants in the HBB gene; relevant for Sardinian, Cypriot, Italian/Sicilian, Greek descent
- Bloom Syndrome1 variant in the BLM gene; relevant for Ashkenazi Jewish descent
- Canavan Disease3 variants in the ASPA gene; relevant for Ashkenazi Jewish descent
- Congenital Disorder of Glycosylation Type 1a (PMM2-CDG)2 variants in the PMM2 gene; relevant for Ashkenazi Jewish, Danish descent
- Cystic Fibrosis29 variants in the CFTR gene; relevant for Ashkenazi Jewish, European, Hispanic/Latino descent
- D-Bifunctional Protein Deficiency2 variants in the HSD17B4 gene
- Dihydrolipoamide Dehydrogenase Deficiency1 variant in the DLD gene; relevant for Ashkenazi Jewish descent
- Familial Dysautonomia1 variant in the ELP1 gene; relevant for Ashkenazi Jewish descent
- Familial Hyperinsulinism (ABCC8-Related)3 variants in the ABCC8 gene; relevant for Ashkenazi Jewish descent
- Familial Mediterranean Fever7 variants in the MEFV gene; relevant for Arab, Armenian, Sephardic Jewish, Turkish descent
- Fanconi Anemia Group C3 variants in the FANCC gene; relevant for Ashkenazi Jewish descent
- GRACILE Syndrome1 variant in the BCS1L gene; relevant for Finnish descent
- Gaucher Disease Type 13 variants in the GBA (also known as GBA1) gene; relevant for Ashkenazi Jewish descent
- Glycogen Storage Disease Type Ia1 variant in the G6PC gene; relevant for Ashkenazi Jewish descent
- Glycogen Storage Disease Type Ib2 variants in the SLC37A4 gene
- Hereditary Fructose Intolerance4 variants in the ALDOB gene; relevant for European descent
- Leigh Syndrome, French Canadian Type1 variant in the LRPPRC gene; relevant for French Canadian descent
- Limb-Girdle Muscular Dystrophy Type 2D1 variant in the SGCA gene
- Limb-Girdle Muscular Dystrophy Type 2E1 variant in the SGCB gene; relevant for Amish descent
- Limb-Girdle Muscular Dystrophy Type 2I1 variant in the FKRP gene
- MCAD Deficiency4 variants in the ACADM gene; relevant for European descent
- Maple Syrup Urine Disease Type 1B2 variants in the BCKDHB gene; relevant for Ashkenazi Jewish descent
- Mucolipidosis Type IV1 variant in the MCOLN1 gene; relevant for Ashkenazi Jewish descent
- Neuronal Ceroid Lipofuscinosis (CLN5-Related)1 variant in the CLN5 gene; relevant for Finnish descent
- Neuronal Ceroid Lipofuscinosis (PPT1-Related)3 variants in the PPT1 gene; relevant for Finnish descent
- Niemann-Pick Disease Type A3 variants in the SMPD1 gene; relevant for Ashkenazi Jewish descent
- Nijmegen Breakage Syndrome1 variant in the NBN gene
- Nonsyndromic Hearing Loss and Deafness, DFNB1 (GJB2-Related)8 variants in the GJB2 gene; relevant for many ethnicities, including Ashkenazi Jewish, East/Southeast Asian, European, and Ghanaian descent. May also be relevant for Hispanic/Latino, Northern African/Middle Eastern, and South Asian descent
- Pendred Syndrome and DFNB4 Hearing Loss (SLC26A4-Related)6 variants in the SLC26A4 gene
- Phenylketonuria and Related Disorders23 variants in the PAH gene; relevant for Irish, Northern European descent
- Pompe Disease5 variants in the GAA gene; relevant for African/African American descent; variants also common in European descent
- Primary Hyperoxaluria Type 21 variant in the GRHPR gene
- Pyruvate Kinase Deficiency1 variant in the PKLR gene
- Rhizomelic Chondrodysplasia Punctata Type 11 variant in the PEX7 gene
- Salla Disease1 variant in the SLC17A5 gene; relevant for Finnish, Swedish descent
- Severe Junctional Epidermolysis Bullosa (LAMB3-Related)3 variants in the LAMB3 gene
- Sickle Cell Anemia1 variant in the HBB gene; relevant for African, Middle Eastern, South Asian, Caribbean, Mediterranean, Central and South American descent
- Sjögren-Larsson Syndrome1 variant in the ALDH3A2 gene; relevant for Swedish descent
- Tay-Sachs Disease4 variants in the HEXA gene; relevant for Ashkenazi Jewish, Cajun descent
- Tyrosinemia Type I4 variants in the FAH gene; relevant for French Canadian, Finnish descent
- Usher Syndrome Type 1F1 variant in the PCDH15 gene; relevant for Ashkenazi Jewish descent
- Usher Syndrome Type 3A1 variant in the CLRN1 gene; relevant for Ashkenazi Jewish descent
- Zellweger Spectrum Disorder (PEX1-Related)1 variant in the PEX1 gene
- Alcohol Flush Reaction
- Caffeine Consumption
- Deep Sleep
- Genetic Weight
- Lactose Intolerance
- Muscle Composition
- Saturated Fat and Weight
- Sleep Movement
Which service will you start with today?
Remember, you can always upgrade without having to spit again.
| Feature | Ancestry Service | Health plus Ancestry Service |
|---|---|---|
Health plus Ancestry | ||
| Total reports | 80+ | 150+ |
| Ancestry and Trait Reports | ||
| DNA Relative Finder and Family Tree (Opt in) | ||
| Health Predisposition reports*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks Learn how your genetics can influence your chances of developing certain health conditions. | 10+ | |
| Carrier Status reports*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks If you are starting a family, find out if you are a carrier for certain inherited conditions. | ||
| Wellness reports Learn how your genes play a role in your well-being and lifestyle choices. | 5+ | |
| Family Health History Tree Opt in to easily input, track and download your family health history to share with your healthcare provider. | ||
| Pharmacogenetics reports**Learn about Considerations and Limitations for Pharmacogenetics Reports Discover how your DNA may impact how your body processes certain medications with three new Pharmacogenetics reports. | ||
| Enhanced ancestry features Get advanced filtering for DNA Relative Finder and access up to 5000 DNA relatives. | ||
| Historical Matches Uncover your historical and ancient relatives, linking you to the past. | ||
Just Added Records & Archives Learn more about your family’s history with the help of historical documents. | ||
| Breast, Prostate and Colorectal Cancer reports Insights into your genetic likelihood of developing breast (females only), prostate (males only) and colorectal (certain ethnicities) cancer. all Powered by 23andMe Research | ||
| Health Tracks See how making healthy choices each day can greatly impact your health over time | ||
| Ongoing new reports and features Get access to new premium reports and features throughout the year. |
Putting insights into action
As more and more people choose DNA testing for health reasons, they’re sharing more and more inspiring stories. These are just a few of the stories of 23andMe Health + Ancestry customers who used what they learned from their DNA to take a more proactive approach to their health.
Watch Charlie’s story
Uncovering a truth
Watch Kristin’s story
Taking action
Watch Charlie’s story
Uncovering a truth
Frequently asked questions
23andMe offers a variety of health reports like Type 2 Diabetes (Powered by 23andMe Research), Celiac Disease Genetic Health Risk Report*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks, BRCA1/BRCA2 (Selected Variants) Genetic Health Risk Report*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks and many more. to see a list of all the reports offered.
Your 23andMe Health reports can tell you how your DNA can impact your chances of developing certain conditions. Wellness reports can help you discover what your DNA has to say about lifestyle factors like diet, exercise, and sleep. And if you're thinking of starting a family, our Carrier Status reports can tell you if you're a carrier for genetic variants linked to certain inherited health conditions.*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks
No, 23andMe reports do not diagnose any health conditions or provide medical advice. While having a particular genetic variant can be linked to a higher risk for a condition, it does not necessarily mean you will develop the condition. It is also important to remember that these reports do not cover all possible genetic variants that could influence risk. Other non-genetic factors, such as environment and lifestyle, can also influence risk for these conditions. We recommend that you consult with a healthcare professional if a condition runs in your family, you think you might have the condition or you have questions about any genetic or non-genetic risk factors you may have.
Stay in the know.
Keep up-to-date with new discoveries and exclusive promotions on our DNA testing kits and services.
*The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of 44 variants in the BRCA1 and BRCA2 genes. The report describes if a person's genetic result is associated with an increased risk of developing breast cancer and ovarian cancer and may be associated with an increased risk for prostate cancer, pancreatic cancer, and potentially other cancers. The variants included in this report do not represent the majority of the BRCA1/BRCA2 variants in people of most ethnicities. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. This report is for over-the-counter use by adults over the age of 18, and provides genetic information to inform discussions with a healthcare professional. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/
**23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Our SLCO1B1 Pharmacogenetics report provides certain information about variants associated with the processing of some therapeutics and provides interpretive drug information regarding the potential effect of simvastatin therapy. Our DPYD Pharmacogenetics report does not describe the association between detected variants and any specific therapeutic. Results for DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For important information and limitations regarding Pharmacogenetic reports, visit 23andme.com/test-info/pharmacogenetics/